← Leaderboards
Hugh S Taylor
Yale University
$17,818,952
Attributed
$26,041,837
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,678,641 · 13
By mechanism
R01$19,651,560 · 6
U54$8,459,562 · 4
K12$3,990,786 · 1
R29$352,114 · 1
R43$224,619 · 1
Top collaborators
- Heping Zhang10 shared
- Ira M Hall4 shared
- Yong-Hui Jiang4 shared
- Uma Reddy4 shared
- James Alan Wingrove1 shared
Most similar at Yale University
Same institution · by research overlap
- Heping Zhang$60,378,422
- Matthew W State$28,201,965
- Elizabeth B. Claus$21,096,464
- Joseph F. Cubells$7,878,696
- David Assis$1,062,762
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanEndometrialEndometriumResearch PersonnelReproductiveFundingAffectProgramsLeadGenesEvaluationUterusPregnancyGene ExpressionFemaleProspectiveTissuesCellsEstrogen ReceptorsInstitutionEndometriosisEstrogensSuccessRodent
Grant awards (66)
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,479,388
R01 · FY2025 · HD
The Yale WRHR Career Development Center$340,199
K12 · FY2025 · HD · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,479,765
R01 · FY2024 · HD
The Yale WRHR Career Development Center$335,504
K12 · FY2024 · HD · contact PI
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4$1,007,337
R01 · FY2023 · HD · contact PI
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4$342,628
R01 · FY2023 · HD · contact PI
The Yale WRHR Career Development Center$336,603
K12 · FY2023 · HD · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,509,604
R01 · FY2022 · HD
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4$1,232,170
R01 · FY2022 · HD · contact PI
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4$344,742
R01 · FY2022 · HD · contact PI
The Yale WRHR Career Development Center$337,801
K12 · FY2022 · HD · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,524,247
R01 · FY2021 · HD
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4$1,248,431
R01 · FY2021 · HD · contact PI
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4$347,239
R01 · FY2021 · HD · contact PI
The Yale WRHR Career Development Center$163,844
K12 · FY2021 · HD · contact PI
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4$1,098,303
R01 · FY2020 · HD · contact PI
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4$354,327
R01 · FY2020 · HD · contact PI
The Yale WRHR Career Development Center$144,744
K12 · FY2020 · HD · contact PI
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4$921,463
R01 · FY2019 · HD · contact PI
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4$335,006
R01 · FY2019 · HD · contact PI
The Yale WRHR Career Development Center$265,404
K12 · FY2019 · HD · contact PI
Multi-center prospective study assessing a panel of microRNAs as a non-invasive test for endometriosis$224,619
R43 · FY2019 · HD
The Yale WRHR Career Development Center$300,483
K12 · FY2018 · HD · contact PI
The Yale WRHR Career Development Center$340,200
K12 · FY2017 · HD · contact PI
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells$412,087
R01 · FY2016 · HD · contact PI
The Yale WRHR Career Development Center$339,971
K12 · FY2016 · HD · contact PI
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells$405,843
R01 · FY2015 · HD · contact PI
The Yale WRHR Career Development Center$135,633
K12 · FY2015 · HD · contact PI
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells$404,595
R01 · FY2014 · HD · contact PI
The Yale WRHR Career Development Center$475,200
K12 · FY2013 · HD · contact PI
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells$395,021
R01 · FY2013 · HD · contact PI
The Yale WRHR Career Development Center$475,200
K12 · FY2012 · HD · contact PI
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells$415,104
R01 · FY2012 · HD · contact PI
Center for Endometrial Biology and Endometriosis$1,280,732
U54 · FY2011 · HD · contact PI
Alteration of HOX Gene Expression by Endocrine Disrupting Chemicals$337,795
R01 · FY2011 · ES · contact PI
Contribution of Adult Bone Marrow-Derived Stem Cells to Endometrium$317,834
U54 · FY2011 · HD · contact PI
Contribution of Adult Bone Marrow-Derived Stem Cells to Endometrium$56,957
U54 · FY2011 · HD · contact PI
Center for Endometrial Biology and Endometriosis$56,957
U54 · FY2011 · HD · contact PI
Center for Endometrial Biology and Endometriosis$1,294,022
U54 · FY2010 · HD · contact PI
Alteration of HOX Gene Expression by Endocrine Disrupting Chemicals$341,208
R01 · FY2010 · ES · contact PI
Contribution of Adult Bone Marrow-Derived Stem Cells to Endometrium$335,640
U54 · FY2010 · HD · contact PI
Center for Endometrial Biology and Endometriosis$1,327,553
U54 · FY2009 · HD · contact PI
Contribution of Adult Bone Marrow-Derived Stem Cells to Endometrium$347,211
U54 · FY2009 · HD · contact PI
Alteration of HOX Gene Expression by Endocrine Disrupting Chemicals$344,654
R01 · FY2009 · ES · contact PI
Center for Endometrial Biology and Endometriosis$217,517
U54 · FY2009 · HD · contact PI
Center for Endometrial Biology and Endometriosis$11,032
U54 · FY2009 · HD · contact PI
Center for Endometrial Biology and Endometriosis$1,206,657
U54 · FY2008 · HD · contact PI
Alteration of HOX Gene Expression by Endocrine Disrupting Chemicals$344,394
R01 · FY2008 · ES · contact PI
Contribution of Adult Bone Marrow-Derived Stem Cells to Endometrium$318,308
U54 · FY2008 · HD · contact PI
Center for Endometrial Biology and Endometriosis$1,242,334
U54 · FY2007 · HD · contact PI
Alteration of HOX Gene Expression by Endocrine Disrupting Chemicals$350,625
R01 · FY2007 · ES · contact PI
Contribution of Adult Bone Marrow-Derived Stem Cells to Endometrium$283,568
U54 · FY2007 · HD · contact PI
Hox Gene Expression in Human Endometrium$279,050
R01 · FY2007 · HD · contact PI
Administrtive Cells$163,240
U54 · FY2007 · HD · contact PI
Hox Gene Expression in Human Endometrium$287,384
R01 · FY2006 · HD · contact PI
Hox Gene Expression in Human Endometrium$294,300
R01 · FY2005 · HD
HOX Gene Expression by Endocrine Disrupting Chemicals$245,250
R01 · FY2005 · ES
Hox Gene Expression in Human Endometrium$294,300
R01 · FY2004 · HD
HOX Gene Expression by Endocrine Disrupting Chemicals$245,250
R01 · FY2004 · ES
Hox Gene Expression in Human Endometrium$294,300
R01 · FY2003 · HD
HOX Gene Expression by Endocrine Disrupting Chemicals$245,250
R01 · FY2003 · ES
HOX Gene Expression by Endocrine Disrupting Chemicals$245,250
R01 · FY2002 · ES
HOX GENE EXPRESSION IN HUMAN ENDOMETRIUM$120,411
R29 · FY2002 · HD
HOX Gene Expression by Endocrine Disrupting Chemicals$245,250
R01 · FY2001 · ES
HOX GENE EXPRESSION IN HUMAN ENDOMETRIUM$117,341
R29 · FY2001 · HD
HOX GENE EXPRESSION IN HUMAN ENDOMETRIUM$114,362
R29 · FY2000 · HD